Benefit-Risk Assessment of Levetiracetam in the Treatment of Partial Seizures

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.10, 2005-01, pp. : 871-890

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer

By Dienstmann Rodrigo

Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. : 15-25

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis

By Mikuls T.R.

Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. : 23-32

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Rofecoxib in the Treatment of Osteoarthritis

By Schmidt H. Woodcock B.G. Geisslinger G.

Drug Safety, Vol. 27, Iss. 3, 2004-01 ,pp. : 185-196

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Dapoxetine in the Treatment of Premature Ejaculation

By Hutchinson Kate Cruickshank Kelly Wylie Kevan

Drug Safety, Vol. 35, Iss. 5, 2012-05 ,pp. : 359-372

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas

By De Leo V. Morgante G. La Marca A. Musacchio M.C. Sorace M. Cavicchioli C. Petraglia F.

Drug Safety, Vol. 25, Iss. 11, 2002-01 ,pp. : 759-779

Adis International

Access to resources Recommend Favorite